Avior Wealth Management LLC Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Avior Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 393.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 385 shares of the exchange traded fund’s stock after buying an additional 307 shares during the period. Avior Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $35,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of XBI. B. Riley Wealth Advisors Inc. grew its position in shares of SPDR S&P Biotech ETF by 144.0% during the second quarter. B. Riley Wealth Advisors Inc. now owns 17,253 shares of the exchange traded fund’s stock worth $1,600,000 after purchasing an additional 10,182 shares in the last quarter. Truist Financial Corp grew its position in shares of SPDR S&P Biotech ETF by 0.8% during the second quarter. Truist Financial Corp now owns 32,773 shares of the exchange traded fund’s stock worth $3,038,000 after purchasing an additional 252 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $1,247,000. Newbridge Financial Services Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 3.4% during the second quarter. Newbridge Financial Services Group Inc. now owns 12,600 shares of the exchange traded fund’s stock worth $1,168,000 after purchasing an additional 419 shares in the last quarter. Finally, M&R Capital Management Inc. grew its position in shares of SPDR S&P Biotech ETF by 25.1% during the third quarter. M&R Capital Management Inc. now owns 1,501 shares of the exchange traded fund’s stock worth $148,000 after purchasing an additional 301 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.6 %

NYSEARCA:XBI opened at $92.58 on Thursday. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a 50-day moving average price of $93.32 and a 200 day moving average price of $96.80. The stock has a market capitalization of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.